Literature DB >> 28333298

Occurrence and molecular characteristics of ESBL/AmpC-producing Escherichia coli in faecal samples from horses in an equine clinic.

Ilias Apostolakos1, Eelco Franz1, Angela H A M van Hoek1, Alice Florijn1, Christiaan Veenman1, Marianne M Sloet-van Oldruitenborgh-Oosterbaan2, Cindy Dierikx1, Engeline van Duijkeren1.   

Abstract

Objectives: To investigate the occurrence and characteristics of ESBL/AmpC-producing Escherichia coli in faecal samples from horses at one equine clinic in the Netherlands.
Methods: A total of 91 horses, including residents and patients, were sampled. ESBL/AmpC-producing E. coli were identified by a combination disc diffusion test. Phylogenetic groups and MLST were determined. ESBL/AmpC genes were analysed using PCR and sequencing. Plasmids were characterized by transformation and PCR-based replicon typing. Subtyping of plasmids was done by plasmid MLST.
Results: At least one E. coli isolate with a confirmed ESBL/AmpC gene was found in samples from 76 horses (84%). Although phylogenetic group B1 E. coli bla CTX-M-1 predominated, a diverse E. coli population was found, indicating that clonal nosocomial spread was not the only reason for the high occurrence found. MLST analysis revealed the presence of 47 E. coli STs, organized in four clusters of genetically related strains. ST10, ST641, ST1079 and ST1250 were most commonly found. With regard to the genes, bla CTX-M-1 was most prevalent ( n  =   91), followed by bla CTX-M-2 ( n  =   26). The most frequently found plasmid type was IncHI1, but plasmids belonging to the IncF, IncI1 and IncN groups were also identified. Conclusions: A high occurrence of ESBL-producing E. coli in faecal samples was found among horses in an equine clinic and the variety of STs, ESBL genes and plasmid types suggests nosocomial transmission. ESBL E. coli can cause difficult-to-treat infections in horses and prudent use of antimicrobials is warranted. A further assessment of the risks of transmission to persons in close contact with horses, such as caretakers or veterinarians, is crucial.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28333298     DOI: 10.1093/jac/dkx072

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  16 in total

1.  Fecal Carriage of Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli in Horses.

Authors:  Joost Hordijk; Evangelia Farmakioti; Lidwien A M Smit; Birgitta Duim; Haitske Graveland; Mathijs J P Theelen; Jaap A Wagenaar
Journal:  Appl Environ Microbiol       Date:  2020-04-01       Impact factor: 4.792

2.  Comparison of approaches for source attribution of ESBL-producing Escherichia coli in Germany.

Authors:  Sara Perestrelo; Guido Correia Carreira; Lars Valentin; Jennie Fischer; Yvonne Pfeifer; Guido Werner; Judith Schmiedel; Linda Falgenhauer; Can Imirzalioglu; Trinad Chakraborty; Annemarie Käsbohrer
Journal:  PLoS One       Date:  2022-07-15       Impact factor: 3.752

3.  Horsing around: Escherichia coli ST1250 of equine origin harbouring epidemic IncHI1/ST9 plasmid with bla CTX-M-1 and an operon for short-chain fructooligosaccharides metabolism.

Authors:  Adam Valcek; Petra Sismova; Kristina Nesporova; Søren Overballe-Petersen; Ibrahim Bitar; Ivana Jamborova; Arie Kant; Jaroslav Hrabak; Jaap A Wagenaar; Jean-Yves Madec; Peter Damborg; Engeline van Duijkeren; Christa Ewers; Joost Hordijk; Henrik Hasman; Michael S M Brouwer; Monika Dolejska
Journal:  Antimicrob Agents Chemother       Date:  2021-02-22       Impact factor: 5.191

4.  Antibiotic-resistant indicator bacteria in irrigation water: High prevalence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.

Authors:  Maria-Theresia Gekenidis; Weihong Qi; Jörg Hummerjohann; Reinhard Zbinden; Fiona Walsh; David Drissner
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

5.  Emergence of carriage of CTX-M-15 in faecal Escherichia coli in horses at an equine hospital in the UK; increasing prevalence over a decade (2008-2017).

Authors:  C M Isgren; T Edwards; G L Pinchbeck; E Winward; E R Adams; P Norton; D Timofte; T W Maddox; P D Clegg; N J Williams
Journal:  BMC Vet Res       Date:  2019-07-29       Impact factor: 2.741

6.  Extended-spectrum β-lactamase-producing Escherichia coli isolated from healthy Thoroughbred racehorses in Japan.

Authors:  Eddy Sukmawinata; Wataru Sato; Shuya Mitoma; Takuya Kanda; Kanichi Kusano; Yoshinori Kambayashi; Takashi Sato; Yuhiro Ishikawa; Yoshitaka Goto; Ryoko Uemura; Masuo Sueyoshi
Journal:  J Equine Sci       Date:  2019-10-02

7.  The Occurrence and Characterization of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Isolated from Clinical Diagnostic Specimens of Equine Origin.

Authors:  Leta Elias; David C Gillis; Tanya Gurrola-Rodriguez; Jeong Ho Jeon; Jung Hun Lee; Tae Yeong Kim; Sang Hee Lee; Sarah A Murray; Naomi Ohta; Harvey Morgan Scott; Jing Wu; Artem S Rogovskyy
Journal:  Animals (Basel)       Date:  2019-12-21       Impact factor: 2.752

8.  Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Acinetobacter baumannii among horses entering a veterinary teaching hospital: The contemporary "Trojan Horse".

Authors:  Birgit Walther; Katja-Sophia Klein; Ann-Kristin Barton; Torsten Semmler; Charlotte Huber; Silver Anthony Wolf; Karsten Tedin; Roswitha Merle; Franziska Mitrach; Sebastian Guenther; Antina Lübke-Becker; Heidrun Gehlen
Journal:  PLoS One       Date:  2018-01-30       Impact factor: 3.240

9.  Antimicrobial Usage in Horses: The Use of Electronic Data, Data Curation, and First Results.

Authors:  Anne Schnepf; Astrid Bienert-Zeit; Hatice Ertugrul; Rolf Wagels; Nicole Werner; Maria Hartmann; Karsten Feige; Lothar Kreienbrock
Journal:  Front Vet Sci       Date:  2020-04-29

10.  Whole Genome Sequencing of Escherichia coli From Store-Bought Produce.

Authors:  Cameron J Reid; Khald Blau; Sven Jechalke; Kornelia Smalla; Steven P Djordjevic
Journal:  Front Microbiol       Date:  2020-01-29       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.